Todd W. Garner - 01 Mar 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Executive Vice President & CFO
Signature
Sarah M. Oliker for Todd W. Garner by Power of Attorney
Issuer symbol
CNMD
Transactions as of
01 Mar 2023
Transactions value $
-$46,734
Form type
4
Filing time
03 Mar 2023, 18:13:31 UTC
Previous filing
12 Dec 2022
Next filing
14 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +1,600 +160,000% $0 1,601 01 Mar 2023 Direct
transaction CNMD Common Stock Tax liability -$46,733 -486 -30% $96.16 1,115 01 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -1,600 -100% $0* 0 01 Mar 2023 Common Stock 1,600 $0 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +32,212 $0 32,212 01 Mar 2023 Common Stock 32,212 $96.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period